J

Joincare Pharmaceutical Group Industry Co Ltd
SSE:600380

Watchlist Manager
Joincare Pharmaceutical Group Industry Co Ltd
SSE:600380
Watchlist
Price: 11.42 CNY 0.26% Market Closed
Market Cap: 21.4B CNY
Have any thoughts about
Joincare Pharmaceutical Group Industry Co Ltd?
Write Note
Joincare Pharmaceutical Group Industry Co Ltd
/
Balance Sheet
/
Long-Term Debt

Joincare Pharmaceutical Group Industry Co Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Joincare Pharmaceutical Group Industry Co Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
J
Joincare Pharmaceutical Group Industry Co Ltd
SSE:600380
Long-Term Debt
¥1.6B
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Long-Term Debt
¥104.5m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Long-Term Debt
¥158.1m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
-6%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Long-Term Debt
¥58.3m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
19%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Long-Term Debt
¥195.6m
CAGR 3-Years
43%
CAGR 5-Years
118%
CAGR 10-Years
42%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Long-Term Debt
¥192.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Joincare Pharmaceutical Group Industry Co Ltd
Glance View

Market Cap
21.4B CNY
Industry
Pharmaceuticals

Joincare Pharmaceutical Group Industry Co. Ltd., a noteworthy player in China's bustling pharmaceutical landscape, emerged as a beacon of innovation and resilience. With its roots stretching back to the mid-1990s, the company has consistently carved out a substantial niche in both the generic and proprietary drug markets. Its ability to synergistically blend cutting-edge research with cost-efficient production has been instrumental in ensuring its position as a formidable competitor. Joincare harnesses a robust pipeline of drugs targeting prevalent chronic diseases, complemented by its investment in high-growth biopharmaceuticals. From research and development to manufacturing and distribution, Joincare manages an integrated pharmaceutical supply chain that not only propels its profitability but also reinforces its mission to enhance public health. The company thrives on a diverse revenue model by leveraging both its proprietary products and a broad array of generic pharmaceuticals. It capitalizes on sustained demand for its products across domestic and international markets, ensuring a steady stream of income. By focusing on quality and affordability, Joincare has successfully navigated the complex regulatory landscape, earning certifications that open doors to global markets. This strategic emphasis on rigorous compliance not only mitigates risks but also builds trust with healthcare professionals and end-users alike. Through these efforts, Joincare continues to fortify its market position, all while contributing to the ever-evolving pharmaceutical industry with a pioneering spirit and an unwavering commitment to improving healthcare accessibility.

Intrinsic Value
18.96 CNY
Undervaluation 40%
Intrinsic Value
Price
J
What is Intrinsic Value?

See Also

What is Joincare Pharmaceutical Group Industry Co Ltd's Long-Term Debt?
Long-Term Debt
1.6B CNY

Based on the financial report for Sep 30, 2024, Joincare Pharmaceutical Group Industry Co Ltd's Long-Term Debt amounts to 1.6B CNY.

What is Joincare Pharmaceutical Group Industry Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
-1%

Over the last year, the Long-Term Debt growth was -60%. The average annual Long-Term Debt growth rates for Joincare Pharmaceutical Group Industry Co Ltd have been 31% over the past three years , and -1% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.